Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Alibaba Health Information Technology 3-Year ROIIC %?
Alibaba Health Information TechnologyALBHF 55 3-Year ROIIC % is 64.35 as of Mar. 2026, which is 969% above its 10-year median of 6.02. GuruFocus rates ALBHF with a GF Score™ of 55/100 and a GF Value™ of $0.67 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 619 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks better than 85.95% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Alibaba Health Information Technology's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 64.35%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
ALBHF's 3-Year ROIIC % is ranked better than 85.95% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.46
vs ALBHF: 64.35
Alibaba Health Information Technology (OTCPK:ALBHF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Alibaba Health Information Technology 3-Year ROIIC % Related Terms
Alibaba Health Information Technology 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology 3-Year ROIIC % Chart
Alibaba Health Information Technology 3-Year ROIIC % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Alibaba Health Information Technology (ALBHF) has a 3-Year ROIIC % of 64.35 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Alibaba Health Information Technology and its competitors. This is 969% above median its historical median of 6.02. According to the industry distribution chart, Alibaba Health Information Technology ranks #87 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 14.1%.
Is Alibaba Health Information Technology's 3-Year ROIIC % too high?
Alibaba Health Information Technology's current 3-Year ROIIC % of 64.35 is 969% above median its 10-year median of 6.02. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.46. Alibaba Health Information Technology's value of 64.35 is 1759.8% above this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #87 out of 619 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alibaba Health Information Technology has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's 3-Year ROIIC % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #87 out of 619 companies for 3-Year ROIIC %. This places Alibaba Health Information Technology in the top 14% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.46. Alibaba Health Information Technology's value of 64.35 is 1759.8% above this benchmark. While the company's 10-year median is 6.02 vs. the industry median of 3.46, Alibaba Health Information Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.46, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current 3-Year ROIIC % of 64.35 is 1759.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current 3-Year ROIIC % is 64.35, which is 969% above median its own 10-year median of 6.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.67, compared to a current price of $0.42 — trading 37.3% below its estimated fair value. The current 3-Year ROIIC % is 64.35, which is 969% above median its 10-year median of 6.02 and 1759.8% above the Healthcare Providers & Services industry median of 3.46. Alibaba Health Information Technology's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current 3-Year ROIIC % is 64.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?
Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued.
The current stock price of $0.42 is trading 37.3% below its estimated GF Value™ of $0.67.
GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.
Key valuation signals for ALBHF:
3-Year ROIIC %: 64.35 (969% above median its 10-year median of 6.02)
GF Value™: $0.67 vs. price of $0.42 (37.3% below fair value)
Industry Position: 1759.8% above the Healthcare Providers & Services median (#87 of 619)
No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alibaba Health Information Technology Business Description
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
55GF Score
Get the complete analysis for ALBHF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALBHF has been successfully added to your 
